BURRAGE CAPITAL MANAGEMENT LLC 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-30 06:02 am Sale |
2021-06-30 | 13G | Protalix BioTherapeutics, Inc. PLX |
BURRAGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-2,470,332 (Position Closed) |
Filing |
| 2021-02-12 12:00 pm Purchase |
2020-12-04 | 13G | Protalix BioTherapeutics, Inc. PLX |
BURRAGE CAPITAL MANAGEMENT LLC | 2,470,332 7.410% |
2,470,332 (New Position) |
Filing |